N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

Catalog No. :
ACLMXH046
CAS No. :
1220696-30-9
Molecular Formula :
C14H23BN2O2
Molecular Weight :
262.16

IUPAC Name:N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$352.00Login to see priceInquiryInquiry
250mg98%$564.00Login to see priceInquiryInquiry
1g98%$1409.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
IUPAC NameN-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
MDL No.MFCD16995203
Molecular FormulaC14H23BN2O2
Molecular Weight262.16
SMILESCC1(C)C(C)(C)OB(C2=CN=C(NC(C)C)C=C2)O1
InChI KeyUQYVTUCDQZOVNM-UHFFFAOYSA-N
SynonymN-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine;N-(1-Methylethyl) -5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-aMine;2-Pyridinamine, N-(1-methylethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1220696-30-9

Synthetic Route by SureRoute

1. ACLMXH046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACLMXH046 route product structure diagram
    ACLMXH0461220696-30-9
Inquiry

2. ACLMXH046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHWR716 route compound structure diagram
    ACDHWR71629552-58-7 In Stock
  2. Plus
  3. ACXIZU058 route compound structure diagram
    ACXIZU058444120-94-9 In Stock
  4. Then
  5. ACLMXH046 route product structure diagram
    ACLMXH0461220696-30-9
Inquiry

Comments (0)